134 related articles for article (PubMed ID: 32492479)
1. Circulating cells and exosomes in acute myelogenous leukemia and their role in disease progression and survival.
Miyamoto KN; Bonatto D
Clin Immunol; 2020 Aug; 217():108489. PubMed ID: 32492479
[TBL] [Abstract][Full Text] [Related]
2. Acute myeloid leukemia transforms the bone marrow niche into a leukemia-permissive microenvironment through exosome secretion.
Kumar B; Garcia M; Weng L; Jung X; Murakami JL; Hu X; McDonald T; Lin A; Kumar AR; DiGiusto DL; Stein AS; Pullarkat VA; Hui SK; Carlesso N; Kuo YH; Bhatia R; Marcucci G; Chen CC
Leukemia; 2018 Mar; 32(3):575-587. PubMed ID: 28816238
[TBL] [Abstract][Full Text] [Related]
3. Utilizing exosomes as sparking clinical biomarkers and therapeutic response in acute myeloid leukemia.
Wang W; Wu X; Zheng J; Yin R; Li Y; Wu X; Xu L; Jin Z
Front Immunol; 2023; 14():1315453. PubMed ID: 38292478
[TBL] [Abstract][Full Text] [Related]
4. RNA trafficking by acute myelogenous leukemia exosomes.
Huan J; Hornick NI; Shurtleff MJ; Skinner AM; Goloviznina NA; Roberts CT; Kurre P
Cancer Res; 2013 Jan; 73(2):918-29. PubMed ID: 23149911
[TBL] [Abstract][Full Text] [Related]
5. Acute Myeloid Leukemia Cells Express ICOS Ligand to Promote the Expansion of Regulatory T Cells.
Han Y; Dong Y; Yang Q; Xu W; Jiang S; Yu Z; Yu K; Zhang S
Front Immunol; 2018; 9():2227. PubMed ID: 30319662
[TBL] [Abstract][Full Text] [Related]
6. The tissue inhibitor of metalloproteinases-1 (TIMP-1) promotes survival and migration of acute myeloid leukemia cells through CD63/PI3K/Akt/p21 signaling.
Forte D; Salvestrini V; Corradi G; Rossi L; Catani L; Lemoli RM; Cavo M; Curti A
Oncotarget; 2017 Jan; 8(2):2261-2274. PubMed ID: 27903985
[TBL] [Abstract][Full Text] [Related]
7. Regulatory T cells in acute myelogenous leukemia: is it time for immunomodulation?
Ustun C; Miller JS; Munn DH; Weisdorf DJ; Blazar BR
Blood; 2011 Nov; 118(19):5084-95. PubMed ID: 21881045
[TBL] [Abstract][Full Text] [Related]
8. Role of Acute Myeloid Leukemia (AML)-Derived exosomes in tumor progression and survival.
Amin AH; Sharifi LMA; Kakhharov AJ; Opulencia MJC; Alsaikhan F; Bokov DO; Majdi HS; Jawad MA; Hammid AT; Shalaby MN; Mustafa YF; Siahmansouri H
Biomed Pharmacother; 2022 Jun; 150():113009. PubMed ID: 35486974
[TBL] [Abstract][Full Text] [Related]
9. Isolation and characterization of CD34+ blast-derived exosomes in acute myeloid leukemia.
Hong CS; Muller L; Boyiadzis M; Whiteside TL
PLoS One; 2014; 9(8):e103310. PubMed ID: 25093329
[TBL] [Abstract][Full Text] [Related]
10. Roles of the bone marrow niche in hematopoiesis, leukemogenesis, and chemotherapy resistance in acute myeloid leukemia.
Wang A; Zhong H
Hematology; 2018 Dec; 23(10):729-739. PubMed ID: 29902132
[TBL] [Abstract][Full Text] [Related]
11. Cytokine-driven differentiation of blasts from patients with acute myelogenous and lymphoblastic leukemia into dendritic cells.
Köhler T; Plettig R; Wetzstein W; Schmitz M; Ritter M; Mohr B; Schaekel U; Ehninger G; Bornhäuser M
Stem Cells; 2000; 18(2):139-47. PubMed ID: 10742386
[TBL] [Abstract][Full Text] [Related]
12. Interaction between the immune system and acute myeloid leukemia: A model incorporating promotion of regulatory T cell expansion by leukemic cells.
Nishiyama Y; Saikawa Y; Nishiyama N
Biosystems; 2018 Mar; 165():99-105. PubMed ID: 29408212
[TBL] [Abstract][Full Text] [Related]
13. Exosomes in acute myeloid leukemia inhibit hematopoiesis.
Boyiadzis M; Whiteside TL
Curr Opin Hematol; 2018 Jul; 25(4):279-284. PubMed ID: 29846239
[TBL] [Abstract][Full Text] [Related]
14. Circulating exosomes carrying an immunosuppressive cargo interfere with cellular immunotherapy in acute myeloid leukemia.
Hong CS; Sharma P; Yerneni SS; Simms P; Jackson EK; Whiteside TL; Boyiadzis M
Sci Rep; 2017 Oct; 7(1):14684. PubMed ID: 29089618
[TBL] [Abstract][Full Text] [Related]
15. Platelet functions and clinical effects in acute myelogenous leukemia.
Foss B; Bruserud O
Thromb Haemost; 2008 Jan; 99(1):27-37. PubMed ID: 18217131
[TBL] [Abstract][Full Text] [Related]
16. The role of platelet/endothelial cell adhesion molecule 1 (CD31) and CD38 antigens in marrow microenvironmental retention of acute myelogenous leukemia cells.
Gallay N; Anani L; Lopez A; Colombat P; Binet C; Domenech J; Weksler BB; Malavasi F; Herault O
Cancer Res; 2007 Sep; 67(18):8624-32. PubMed ID: 17875702
[TBL] [Abstract][Full Text] [Related]
17. Significance of Frequencies, Compositions, and/or Antileukemic Activity of (DC-stimulated) Invariant NKT, NK and CIK Cells on the Outcome of Patients With AML, ALL and CLL.
Boeck CL; Amberger DC; Doraneh-Gard F; Sutanto W; Guenther T; Schmohl J; Schuster F; Salih H; Babor F; Borkhardt A; Schmetzer H
J Immunother; 2017; 40(6):224-248. PubMed ID: 28557814
[TBL] [Abstract][Full Text] [Related]
18. The role of the immunosuppressive microenvironment in acute myeloid leukemia development and treatment.
Isidori A; Salvestrini V; Ciciarello M; Loscocco F; Visani G; Parisi S; Lecciso M; Ocadlikova D; Rossi L; Gabucci E; Clissa C; Curti A
Expert Rev Hematol; 2014 Dec; 7(6):807-18. PubMed ID: 25227702
[TBL] [Abstract][Full Text] [Related]
19. Remodeling of Bone Marrow Niches and Roles of Exosomes in Leukemia.
Yamaguchi T; Kawamoto E; Gaowa A; Park EJ; Shimaoka M
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33668652
[TBL] [Abstract][Full Text] [Related]
20. Reversible suppression of T cell function in the bone marrow microenvironment of acute myeloid leukemia.
Lamble AJ; Kosaka Y; Laderas T; Maffit A; Kaempf A; Brady LK; Wang W; Long N; Saultz JN; Mori M; Soong D; LeFave CV; Huang F; Adams H; Loriaux MM; Tognon CE; Lo P; Tyner JW; Fan G; McWeeney SK; Druker BJ; Lind EF
Proc Natl Acad Sci U S A; 2020 Jun; 117(25):14331-14341. PubMed ID: 32513686
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
